Category icon
Colchicine in Patients with Coronary Artery Disease

Francesco Condello, Matteo Sturla, Bernhard Reimers, et al

Category icon
Non-culprit Lesion PCI in STEMI Patients

Luigi Di Serafino, Fabio Magliulo, Giovanni Esposito,

Category icon
Patient Radiation Exposure During Primary Percutaneous Coronary…

Emily Mae L Yap, Christopher A Macaraeg, Richard Ayuson, et al

Category icon
Door-to-balloon Time in the COVID-19 Era

Haytham Mously, Nischay Shah, Zachary Zuzek, et al

Category icon
SSO2 Therapy in STEMI to Reduce Infarct Size

Steven Yakubov, Andreas Schäfer, Richard Schatz et al

Category icon
Precision Diagnostics in LM Bifurcation Disease

José M de la Torre Hernández, Tamara García Camarero, Andrew SP Sharp et al

About

Acute coronary syndrome (ACS) is one of the most common health problems globally and a leading cause of death and signficiant morbidity in developed countries. It represents a clinical condition characterised by rapidly developing critical myocardial ischaemia. ACS encompasses three related but distinct clinical entities – unstable angina, non-ST-segment elevation MI (NSTEMI), and ST-segment elevation MI (STEMI).

Acute coronary syndromes are characterised by vascular inflammation, subsequent endothelial dysfunction and platelet activation, followed by thrombus formation. Uncontrolled thrombosis can culminate in complete vascular occlusion and STEMI.

Key diagnostic procedures for detection of patients with ACS are ECG at rest and markers of myocardial necrosis. Optical coherence tomography can be used to assess patients with ACS and is useful because it can detect plaques at high risk of rupture and provide additional information about plaque composition, thrombi and collagen. Troponin T and troponin I are specific cardiac markers for myocardial injury and diagnosing the myocardial necrosis.

Management of ACS should encompass both acute and long-term strategies.

What is Myocardial Infarction?

Also known as a heart attack, myocardial infarction (MI) is a necrosis of the heart muscle that originates from an acute obstruction of a coronary artery. It decreases blood flow and leads to irreversible damage to the heart due to myocardial ischaemia.

Related Articles

Articles

Colchicine in Patients with Coronary Artery Disease

Francesco Condello, Matteo Sturla, Bernhard Reimers,

Published:

Citation: European Cardiology Review 2021;16:e39.

CV Risk Biomarkers in Women with Prior Preeclampsia/HELLP Syndrome

Esmee ME Bovee, Martha Gulati, Angela Maas,

Published:

Citation: European Cardiology Review 2021;16:e36.

Advanced Cardiac Interventions During Pregnancy: A Personal Perspective

Angela Maas,

Published:

Citation: Interventional Cardiology Review 2021;16:e25.

Non-culprit Lesion PCI in STEMI Patients

Luigi Di Serafino, Fabio Magliulo, Giovanni Esposito,

Published:

Citation: Interventional Cardiology Review 2021;16:e24.